{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:01:02Z","timestamp":1792706462348,"version":"4.5.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T00:00:00Z","timestamp":1447113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0141231","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T19:08:13Z","timestamp":1447182493000},"page":"e0141231","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Progression of Alport Kidney Disease in Col4a3 Knock Out Mice Is Independent of Sex or Macrophage Depletion by Clodronate Treatment"],"prefix":"10.1371","volume":"10","author":[{"given":"Munkyung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Piaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeta","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berangere","family":"Gapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Kueng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Ksiazek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,11,10]]},"reference":[{"key":"ref1","first-page":"1241","article-title":"X-linked inheritance of Alport syndrome: family P revisited","volume":"35","author":"SJ Hasstedt","year":"1983","journal-title":"Am J Hum Genet"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2011.237","article-title":"Clinical utility gene card for: Alport syndrome","volume":"20","author":"JM Hertz","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/jmg.34.4.326","article-title":"Alport's syndrome","volume":"34","author":"F Flinter","year":"1997","journal-title":"J Med Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrneph.2012.259","article-title":"Alport syndrome\u2014insights from basic and clinical research","volume":"9","author":"J Kruegel","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ki.2013.493","article-title":"A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen alpha3alpha4alpha5(IV) trimers","volume":"85","author":"R Korstanje","year":"2014","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1101\/gad.10.23.2981","article-title":"Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome","volume":"10","author":"D Cosgrove","year":"1996","journal-title":"Genes Dev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1083\/jcb.135.5.1403","article-title":"Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): implications for Alport syndrome","volume":"135","author":"JH Miner","year":"1996","journal-title":"J Cell Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1097\/01.ASN.0000130562.90255.8F","article-title":"Mouse model of X-linked Alport syndrome","volume":"15","author":"MN Rheault","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1523-1755.2003.00779.x","article-title":"Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome","volume":"63","author":"O Gross","year":"2003","journal-title":"Kidney Int"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ki.2011.407","article-title":"Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy","volume":"81","author":"O Gross","year":"2012","journal-title":"Kidney Int"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/ki.2011.452","article-title":"Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations","volume":"81","author":"J Temme","year":"2012","journal-title":"Kidney Int"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/ng0994-77","article-title":"Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome","volume":"8","author":"T Mochizuki","year":"1994","journal-title":"Nat Genet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"12719","DOI":"10.1074\/jbc.275.17.12719","article-title":"Assembly of type IV collagen. Insights from alpha3(IV) collagen-deficient mice","volume":"275","author":"R Kalluri","year":"2000","journal-title":"J Biol Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9343(61)90107-3","article-title":"Hereditary nephropathy, deafness and renal foam cells","volume":"31","author":"RE Whalen","year":"1961","journal-title":"Am J Med"},{"key":"ref15","first-page":"1338","article-title":"Monocytes may promote myofibroblast accumulation and apoptosis in Alport renal fibrosis","volume":"63","author":"KD Rodgers","year":"2003","journal-title":"Kidney Int"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.2353\/ajpath.2010.100017","article-title":"Collagen XIII induced in vascular endothelium mediates alpha1beta1 integrin-dependent transmigration of monocytes in renal fibrosis","volume":"177","author":"J Dennis","year":"2010","journal-title":"Am J Pathol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1681\/ASN.2004100871","article-title":"Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease","volume":"16","author":"V Ninichuk","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/path.2505","article-title":"Ccl2\/Mcp-1 blockade reduces glomerular and interstitial macrophages but does not ameliorate renal pathology in collagen4A3-deficient mice with autosomal recessive Alport nephropathy","volume":"218","author":"S Clauss","year":"2009","journal-title":"J Pathol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0022-1759(96)00056-7","article-title":"Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine","volume":"193","author":"N van Rooijen","year":"1996","journal-title":"J Immunol Methods"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-1759(94)90012-4","article-title":"Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications","volume":"174","author":"N Van Rooijen","year":"1994","journal-title":"J Immunol Methods"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1254\/jphs.09227FP","article-title":"Effects of Liposome Clodronate on Renal Leukocyte Populations and Renal Fibrosis in Murine Obstructive Nephropathy","volume":"111","author":"K Kitamoto","year":"2009","journal-title":"Journal of Pharmacological Sciences"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/ndt\/gfk047","article-title":"Macrophages contribute to the initiation of ischaemic acute renal failure in rats","volume":"21","author":"SK Jo","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13539-011-0019-5","article-title":"Wasting in chronic kidney disease","volume":"2","author":"RH Mak","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jbmr.516","article-title":"Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease","volume":"27","author":"JR Stubbs","year":"2012","journal-title":"J Bone Miner Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"34182","DOI":"10.1074\/jbc.M102859200","article-title":"Global gene expression analysis reveals a role for the alpha 1 integrin in renal pathogenesis","volume":"276","author":"NS Sampson","year":"2001","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.V84604","article-title":"Cells isolated from the human cortical interstitium resemble myofibroblasts and bind neutrophils in an ICAM-1\u2014dependent manner","volume":"8","author":"A Clayton","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00441-007-0437-z","article-title":"Thy-1 is an in vivo and in vitro marker of liver myofibroblasts","volume":"329","author":"J Dudas","year":"2007","journal-title":"Cell Tissue Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/eji.1830111013","article-title":"F4\/80, a monoclonal antibody directed specifically against the mouse macrophage","volume":"11","author":"JM Austyn","year":"1981","journal-title":"Eur J Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1172\/JCI36150","article-title":"Macrophage diversity in renal injury and repair","volume":"118","author":"SD Ricardo","year":"2008","journal-title":"J Clin Invest"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.immuni.2005.10.001","article-title":"Macrophage polarization comes of age","volume":"23","author":"A Mantovani","year":"2005","journal-title":"Immunity"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"S Gordon","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1440-1797.2010.01439.x","article-title":"Alteration in the phenotype of macrophages in the repair of renal interstitial fibrosis in mice","volume":"16","author":"T Kushiyama","year":"2011","journal-title":"Nephrology (Carlton)"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1097\/01.ASN.0000088027.54400.C6","article-title":"Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury","volume":"14","author":"J Mishra","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1074\/jbc.273.7.4135","article-title":"Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury","volume":"273","author":"T Ichimura","year":"1998","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1939-1676.2012.00891.x","article-title":"Urinary biomarkers of renal disease in dogs with X-linked hereditary nephropathy","volume":"26","author":"MB Nabity","year":"2012","journal-title":"J Vet Intern Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1681\/ASN.2010030269","article-title":"Macrophages in renal disease","volume":"22","author":"Y Wang","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1681\/ASN.2009060615","article-title":"Distinct macrophage phenotypes contribute to kidney injury and repair","volume":"22","author":"S Lee","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.4049\/jimmunol.0901473","article-title":"Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations","volume":"183","author":"SL Lin","year":"2009","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1038\/jid.2014.206","article-title":"Depletion of M2-like tumor-associated macrophages delays cutaneous T-cell lymphoma development in vivo","volume":"134","author":"X Wu","year":"2014","journal-title":"J Invest Dermatol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.humpath.2009.08.024","article-title":"Interstitial inflammation in Alport syndrome","volume":"41","author":"J Jedlicka","year":"2010","journal-title":"Hum Pathol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/labinvest.3700715","article-title":"Lymphocytes are dispensable for glomerulonephritis but required for renal interstitial fibrosis in matrix defect-induced Alport renal disease","volume":"88","author":"VS Lebleu","year":"2008","journal-title":"Lab Invest"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/ndt\/gfl810","article-title":"Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome","volume":"22","author":"ML Koepke","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 4","key":"ref43","doi-asserted-by":"crossref","first-page":"iv124","DOI":"10.1093\/ndt\/gfu028","article-title":"Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS blockade and the horizon of future therapies","volume":"29","author":"O Gross","year":"2014","journal-title":"Nephrol Dial Transplant"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0141231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T20:20:08Z","timestamp":1653510008000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0141231"}},"subtitle":[],"editor":[{"given":"David","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,10]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0141231","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,10]]}}}